Relapsed mantle cell lymphoma
Clinical trials for Relapsed mantle cell lymphoma explained in plain language.
Never miss a new study
Get alerted when new Relapsed mantle cell lymphoma trials appear
Sign up with your email to follow new studies for Relapsed mantle cell lymphoma, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug combo shows promise for Tough-to-Treat lymphoma
Disease control OngoingThis phase 2 trial is testing whether the drug loncastuximab tesirine, given after a short course of chemotherapy, can help people with mantle cell lymphoma whose cancer has returned or not responded to previous treatments, including BTK inhibitors. About 49 participants will rec…
Matched conditions: RELAPSED MANTLE CELL LYMPHOMA
Phase 2 • Sponsor: Fondazione Italiana Linfomi - ETS • Aim: Disease control
Last updated Aug 26, 2026 00:00 UTC
-
New hope for tough lymphoma: sonrotoclax trial underway
Disease control OngoingThis study tests a drug called sonrotoclax (BGB-11417) in 125 people with mantle cell lymphoma that has relapsed or not responded to prior treatments. The trial has two parts: first to find the safest dose, then to see how well it shrinks tumors. Participants take the drug by mou…
Matched conditions: RELAPSED MANTLE CELL LYMPHOMA
Phase 1/2 • Sponsor: BeiGene • Aim: Disease control
Last updated Jun 26, 2026 14:39 UTC